Paul A. Mahon - Jan 6, 2022 Form 4/A - Amendment Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Jan 6, 2022
Transactions value $
-$488,787
Form type
4/A - Amendment
Date filed
3/4/2022, 03:33 PM
Date Of Original Report
Jan 6, 2022
Previous filing
Dec 17, 2021
Next filing
Jan 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $666K +6K +16.5% $111.00 42.4K Jan 6, 2022 Direct F1, F2
transaction UTHR Common Stock Sale -$61K -320 -0.76% $190.48 42K Jan 6, 2022 Direct F1, F3
transaction UTHR Common Stock Sale -$571K -2.97K -7.06% $192.32 39.1K Jan 6, 2022 Direct F1, F4
transaction UTHR Common Stock Sale -$523K -2.71K -6.93% $192.85 36.4K Jan 6, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Options Options Exercise $0 -6K -84.58% $0.00 1.09K Jan 6, 2022 Common Stock 6K $111.00 Direct F1, F6
holding UTHR Stock Options 81.5K Jan 6, 2022 Common Stock 81.5K $111.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
F2 This acquisition of common stock was inadvertently omitted from Table I on the original filing due to administrative error, although the corresponding option exercise was included on Table II. As a result, three subsequent Form 4 filings also incorrectly understated the reporting person's common stock balance by 6,000 shares (filed on January 20, 2022, February 3, 2022, and February 17, 2022).
F3 This transaction was executed in multiple trades at prices ranging from $190.32 to $190.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $191.65 to $192.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $192.65 to $193.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 The reporting person received two stock option grants, both with the same grant date and exercise price. Due to administrative error, previous option exercises occasionally were reported on Table II as having been drawn from the wrong tranche. This balance has been updated to correct these errors.